STAAR Surgical Co (STAA) stock
STAANasdaqOphthalmic GoodsFiscal year ends January 2
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3067% above fair value
$25.56−0.45 (-1.73%)
Close on Nov 17, 2026Market cap $1.28BP/E 365.1Yield –
STAAR Surgical pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
STAAR Surgical's pe ratio was 381.3× on Nov 11, 2026, against 134.0× a year earlier. Over the last 5 years it ranged from 55.0× to 878.4×, with a median of 134.0×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 381.3× | +326.3 |
| 2025 | Jan 31, 2025 | 55.0× | −0.2 |
| 2024 | Dec 31, 2024 | 55.2× | −20.9 |
| 2023 | Dec 29, 2023 | 76.1× | +12.3 |
| 2022 | Dec 30, 2022 | 63.9× | −134.6 |
| 2021 | Dec 31, 2021 | 198.5× | −218.5 |
| 2020 | Dec 31, 2020 | 416.9× | +221.6 |
| 2019 | Dec 31, 2019 | 195.4× | −203.5 |
| 2018 | Dec 31, 2018 | 398.9× | +227.5 |
| 2012 | Jul 31, 2012 | 171.3× | −517.8 |
| 2011 | Dec 30, 2011 | 689.1× | – |
See a number that looks wrong?